Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

A show of hands at the ACC town hall demonstrated unity as specialists investigate options for a new certifying board outside the current one or with two parent sponsors.